Janney Montgomery Scott LLC grew its holdings in Danaher Co. (NYSE:DHR) by 6.2% in the third quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 118,488 shares of the conglomerate’s stock after buying an additional 6,897 shares during the quarter. Janney Montgomery Scott LLC’s holdings in Danaher were worth $12,875,000 at the end of the most recent reporting period.
Several other large investors have also made changes to their positions in DHR. IMS Capital Management acquired a new stake in shares of Danaher in the second quarter valued at $107,000. BerganKDV Wealth Management LLC acquired a new stake in shares of Danaher in the second quarter valued at $111,000. Fort L.P. acquired a new stake in shares of Danaher in the second quarter valued at $119,000. Braun Bostich & Associates Inc. increased its stake in shares of Danaher by 506.4% in the second quarter. Braun Bostich & Associates Inc. now owns 1,225 shares of the conglomerate’s stock valued at $121,000 after buying an additional 1,023 shares in the last quarter. Finally, Reilly Financial Advisors LLC increased its stake in shares of Danaher by 62.6% in the third quarter. Reilly Financial Advisors LLC now owns 1,301 shares of the conglomerate’s stock valued at $141,000 after buying an additional 501 shares in the last quarter. Institutional investors own 76.80% of the company’s stock.
Shares of DHR stock opened at $104.39 on Friday. The company has a debt-to-equity ratio of 0.38, a current ratio of 1.53 and a quick ratio of 1.08. The stock has a market capitalization of $72.94 billion, a P/E ratio of 25.90, a PEG ratio of 2.00 and a beta of 1.04. Danaher Co. has a 12 month low of $91.65 and a 12 month high of $110.13.
Danaher (NYSE:DHR) last announced its quarterly earnings data on Thursday, October 18th. The conglomerate reported $1.10 EPS for the quarter, topping the Zacks’ consensus estimate of $1.07 by $0.03. The firm had revenue of $4.85 billion during the quarter, compared to analyst estimates of $4.80 billion. Danaher had a return on equity of 11.59% and a net margin of 14.07%. The company’s revenue was up 7.2% on a year-over-year basis. During the same period last year, the company earned $1.00 earnings per share. Equities analysts anticipate that Danaher Co. will post 4.51 earnings per share for the current fiscal year.
The business also recently announced a quarterly dividend, which was paid on Friday, October 26th. Shareholders of record on Friday, September 28th were issued a dividend of $0.16 per share. This represents a $0.64 dividend on an annualized basis and a yield of 0.61%. The ex-dividend date was Thursday, September 27th. Danaher’s dividend payout ratio (DPR) is currently 15.88%.
In other Danaher news, Director Donald J. Ehrlich sold 10,578 shares of the firm’s stock in a transaction dated Tuesday, October 23rd. The stock was sold at an average price of $95.77, for a total transaction of $1,013,055.06. Following the transaction, the director now owns 105,491 shares in the company, valued at $10,102,873.07. The sale was disclosed in a document filed with the SEC, which is available through this link. Also, CFO Daniel L. Comas sold 36,000 shares of the firm’s stock in a transaction dated Thursday, November 8th. The stock was sold at an average price of $103.88, for a total value of $3,739,680.00. Following the transaction, the chief financial officer now owns 124,218 shares in the company, valued at approximately $12,903,765.84. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 150,007 shares of company stock worth $15,202,163. Company insiders own 11.90% of the company’s stock.
A number of analysts have recently weighed in on DHR shares. Bank of America set a $113.00 target price on Danaher and gave the company a “buy” rating in a research note on Thursday, July 19th. Zacks Investment Research lowered Danaher from a “buy” rating to a “hold” rating in a research report on Friday, October 12th. Morgan Stanley lifted their price objective on Danaher from $122.00 to $126.00 and gave the stock an “overweight” rating in a research report on Wednesday, October 10th. Royal Bank of Canada lifted their price objective on Danaher to $107.00 and gave the stock a “positive” rating in a research report on Thursday, July 19th. They noted that the move was a valuation call. Finally, Robert W. Baird lowered their price objective on Danaher from $116.00 to $114.00 and set an “outperform” rating for the company in a research report on Friday, October 19th. One investment analyst has rated the stock with a hold rating and fifteen have given a buy rating to the company’s stock. Danaher presently has an average rating of “Buy” and a consensus price target of $112.14.
TRADEMARK VIOLATION NOTICE: This news story was published by American Banking News and is the property of of American Banking News. If you are reading this news story on another domain, it was copied illegally and republished in violation of US & international copyright and trademark legislation. The legal version of this news story can be accessed at https://www.americanbankingnews.com/2018/11/10/janney-montgomery-scott-llc-increases-stake-in-danaher-co-dhr.html.
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company's Life Sciences segment provides laser scanning, compound, surgical, and other stereo microscopes. This segment also offers filtration, separation, and purification technologies to the biopharmaceutical, food and beverage, medical, aerospace, microelectronics, and general industrial sectors.
Read More: How analysts view the yield curve
Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.